IRENE NEVAREZ

Physician Assistants & Advanced Practice Nursing Providers|Nurse Practitioner SAN DIEGO, CA NPI 1003166646

General Payments — all program years on this page

$1,778.95

  • Category: General Payments
  • Program years: PY2021–2024
  • Record count: 78
  • As of (CMS publication): 2026-01-23

Latest program year (PY2024): $400.43 across 20 records · disputed records: 0

Financial relationships do not necessarily indicate an improper relationship; the data is open to interpretation.

How this figure is calculated
  • The total is the sum of the General Payments records CMS published for the labeled program year(s), exactly as published. Nothing is estimated, weighted, or combined across categories.
  • General Payments only. Research and Ownership/Investment are separate datasets and are never summed with these figures; amounts are kept separate per program year.
  • Featured-page threshold (a presentation gate, not a judgment): records>=3 OR total>=100 (all years).
  • Methodology & Data — sourcing, labeling, and limitations.

By nature of payment

Latest program year (PY2024) · sorted by reported total.

Nature of paymentAmountRecords
Food and Beverage $400.4320

By paying entity

Latest program year (PY2024) · sorted by reported total.

By program year

Program yearAmountRecords
2021 $145.552
2022 $289.3213
2023 $943.6543
2024 $400.4320

Records — PY2024 (20)

Record IDPaying entityAmountDate Nature of paymentDispute statusPublishedSource
1077939102 Janssen Pharmaceuticals, Inc $24.58 02/28/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120562290 Alkermes, Inc. $19.60 05/14/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120562292 Alkermes, Inc. $16.90 07/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1120562294 Alkermes, Inc. $18.01 09/17/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133960765 Vanda Pharmaceuticals Inc. $23.59 02/12/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133960767 Vanda Pharmaceuticals Inc. $13.81 07/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133960769 Vanda Pharmaceuticals Inc. $25.03 08/26/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1133960771 Vanda Pharmaceuticals Inc. $27.54 09/09/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143568108 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.91 02/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143568112 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.09 05/07/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143568116 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.52 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1143568120 ITI, Inc. (d/b/a Intra-Cellular Therapies, Inc.) $13.70 09/10/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144565134 Indivior Inc. $29.24 01/29/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1144565136 Indivior Inc. $14.74 02/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1146067097 Lundbeck LLC $13.86 07/18/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150185112 Tempus AI, Inc $26.79 06/25/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150965091 Neurocrine Biosciences, Inc. $22.78 12/16/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1150988946 Neurocrine Biosciences, Inc. $18.20 11/19/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647043 Teva Pharmaceuticals USA, Inc. $30.75 03/05/2024 Food and Beverage Undisputed 01/23/2026 View at CMS
1151647063 Teva Pharmaceuticals USA, Inc. $20.79 04/23/2024 Food and Beverage Undisputed 01/23/2026 View at CMS

Provenance & corrections

  • Dataset: CMS Open Payments — General Payments
  • Source: CMS Open Payments dataset (bulk file)
  • Publisher of source data: Centers for Medicare & Medicaid Services
  • Generated from: OP_DTL_GNRL_PGYR2024_P01232026_01102026.csv

One page per canonical provider; split Profile_IDs are merged via Associated_Covered_Recipient_Profile_ID_1/_2 from the Covered Recipient Profile Supplement.

Corrections to the substance of a record route to CMS through its review-and-dispute process; errors in how this site mirrors or displays a record route to us. Both paths are described in Methodology & Data.